|
LEXX Lexaria Bioscience Corp 1348362 |
| Balance Sheet |
|
Current Assets
|
$5,770,282.00 |
|
Assets
|
$6,487,303.00 |
|
Current Liabilities
|
$214,671.00 |
|
Liabilities
|
$276,997.00 |
|
Equity
|
$6,602,497.00 |
|
Shares Out
|
24887446.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,147,970.00 |
|
Investing Cash Flow
|
$-59,008.00 |
| Market Analysis |
Market Cap
|
$9,954,978.40 |
|
Price
|
$5.22 |
|
BVPS
|
0.27 |
|
PB
|
1.48 |
|
EPS
|
-0.06 |
|
PS
|
18.94 |
|
FCF
|
$-3,188,786.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:44 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:44 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LEXX documents filed with the SEC.
LEXX Filings
Clear
